About this event:
“The Promise of Psychedelic-Assisted Psychotherapy: A Paradigm Shift in Mental Health”
Presented by Tom Neilson, Psy.D. , Licensed Clinical Psychologist, Tennessee
A paradigm shift appears to be underway in the mental health field. The U.S. Food and Drug Administration (FDA) has granted breakthrough status to both MDMA-Assisted Psychotherapy for Post-Traumatic Stress Disorder (PTSD) and for Psilocybin-Assisted Psychotherapy for clinical depression and for end-of life anxiety. This presentation will briefly address the urgent need for new treatments for depression and PTSD, and will include information about newly discovered limitations of traditional antidepressants, such as their loss of efficacy over time and evidence that their long-term use can cause Tardive Dysphoria, an iatrogenic severe, chronic depression. The therapeutic use of MDMA and Ketamine will be briefly addressed; however, this presentation will focus mainly on Psilocybin-Assisted Psychotherapy. Practices and procedures will be reviewed, as well as research that shows Psychedelic-Assisted Psychotherapy to be remarkably effective. Current models of the therapeutic action of Psilocybin-Assisted Psychotherapy will be presented, including models from current neuroscience, the groundbreaking concept of Pivotal Mental States (PiMS), and the role of mystical and transpersonal experiences in Psychedelic-Assisted Psychotherapy outcomes. Finally, a holistic model for Psychedelic-Assisted Psychotherapy will be presented.
1. Participants will be able to define Tardive Dysphoria.
2. Participants will be able to describe the effects of psilocybin, MDMA, and Ketamine in a therapeutic setting.
3. Participants will be able to describe 5-6 common practices and procedures in Psychedelic-Assisted Psychotherapy.
4. Participants will be able to cite research showing the efficacy of Psilocybin-Assisted Psychotherapy.
5. Participants will be able to describe three proposed neurobiological mechanisms operating in Psilocybin-Assisted Psychotherapy.
6. Participants will be able to describe the role of mystical and transpersonal experiences in Psychedelic-Assisted Psychotherapy.
About the presenter:
Tom Neilson, Psy.D. is a clinical psychologist in private practice in Nashville. He earned a B.A. in psychology from Wake Forest University, an M.A. in clinical psychology from Appalachian State University, and a Psy.D. in clinical psychology from Florida Institute of Technology. He has worked in the community mental health field, he has been Director of Training of an APA-accredited internship for psychologists, and he has been in private practice for 24 years. In 2020, Dr. Neilson was admitted to the California Institute of Integral Studies Certificate Program in Psychedelic Psychotherapy and Research, which he anticipates completing in March 2021.
This is a VIRTUAL EVENT using the Zoom Platform. Attendees will receive a link to join the Zoom meeting on Thursday, April 8, 2021, along with any support materials provided by the presenter.